Terms: = Germ cell tumor AND HER1, YOR227W AND Treatment
12 results:
1. Dacomitinib: an investigational drug for the treatment of glioblastoma.
Sepúlveda JM; Sánchez-Gómez P; Vaz Salgado MÁ; Gargini R; Balañá C
Expert Opin Investig Drugs; 2018 Oct; 27(10):823-829. PubMed ID: 30247945
[TBL] [Abstract] [Full Text] [Related]
2. Simultaneous Interference with her1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma cells in Vitro.
Karpel-Massler G; Westhoff MA; Kast RE; Dwucet A; Karpel-Massler S; Nonnenmacher L; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
Neurochem Res; 2017 May; 42(5):1543-1554. PubMed ID: 28271323
[TBL] [Abstract] [Full Text] [Related]
3. Combined inhibition of her1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.
Karpel-Massler G; Westhoff MA; Zhou S; Nonnenmacher L; Dwucet A; Kast RE; Bachem MG; Wirtz CR; Debatin KM; Halatsch ME
Mol Cancer Ther; 2013 Sep; 12(9):1783-95. PubMed ID: 23832120
[TBL] [Abstract] [Full Text] [Related]
4. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract] [Full Text] [Related]
5. Vandetanib: first global approval.
Commander H; Whiteside G; Perry C
Drugs; 2011 Jul; 71(10):1355-65. PubMed ID: 21770481
[TBL] [Abstract] [Full Text] [Related]
6. Drug combinations enhancing the antineoplastic effects of erlotinib in high-grade glioma.
Karpel-Massler G; Wirtz CR; Halatsch ME
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):384-94. PubMed ID: 21612575
[TBL] [Abstract] [Full Text] [Related]
7. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
[TBL] [Abstract] [Full Text] [Related]
8. ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839).
Djerf EA; Trinks C; Abdiu A; Thunell LK; Hallbeck AL; Walz TM
Melanoma Res; 2009 Jun; 19(3):156-66. PubMed ID: 19434003
[TBL] [Abstract] [Full Text] [Related]
9. Epidermal growth factor can induce apoptosis in neuroblastoma.
Chiu B; Mirkin B; Madonna MB
J Pediatr Surg; 2007 Mar; 42(3):482-8. PubMed ID: 17336184
[TBL] [Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
Halatsch ME; Schmidt U; Behnke-Mursch J; Unterberg A; Wirtz CR
Cancer Treat Rev; 2006 Apr; 32(2):74-89. PubMed ID: 16488082
[TBL] [Abstract] [Full Text] [Related]
11. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.
Ho R; Minturn JE; Hishiki T; Zhao H; Wang Q; Cnaan A; Maris J; Evans AE; Brodeur GM
Cancer Res; 2005 Nov; 65(21):9868-75. PubMed ID: 16267010
[TBL] [Abstract] [Full Text] [Related]
12. her1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
Raizer JJ
J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
[TBL] [Abstract] [Full Text] [Related]
